Tumor angiogenesis of non-small cell lung cancer

被引:38
|
作者
Shijubo, N
Kojima, H
Nagata, M
Ohchi, T
Suzuki, A
Abe, S
Sato, N
机构
[1] Sapporo Med Univ, Sch Med, Dept Internal Med 3, Chuo Ku, Sapporo, Hokkaido 0608543, Japan
[2] Sapporo Med Univ, Sch Med, Dept Pathol, Chuo Ku, Sapporo, Hokkaido 0608543, Japan
关键词
VEGF; bFGF; PD-ECGF; chemokine; MMP; VE-cadherin; integrin; osteopontin; mast cells;
D O I
10.1002/jemt.10257
中图分类号
R602 [外科病理学、解剖学]; R32 [人体形态学];
学科分类号
100101 ;
摘要
Lung cancer is one of the commonest causes of cancer death in developed countries. Recent evidence suggests that angoigenesis is related to poor prognosis in many solid tumors including non-small cell lung cancer (NSCLC). Angiogenesis is regulated by a complex interaction among growth factors and cytokines and influenced by proteolytic enzymes such as plasminogen activators and matrix metalloproteases, expression of adhesion molecules, and distribution of extracellular matrices. Fibroblasts, macrophages, mast cells, and endothelial cells themselves also affect angiogenesis. This review concentrates on angiogenic growth factors including vascular endothelial growth factor, angiopoietins, platelet derived endothelial growth factor, and basic fibroblast growth factor, proteases, adhesion molecules including vascular endothelial cadherin and integrins, osteopontin, and mast cell products in tumor angiogenesis of NSCLC. (C) 2003 Wiley-Liss, Inc.
引用
收藏
页码:186 / 198
页数:13
相关论文
共 50 条
  • [1] Angiogenesis and non-small cell lung cancer
    Cox, G
    Jones, JL
    Walker, RA
    Steward, WP
    O'Byrne, KJ
    LUNG CANCER, 2000, 27 (02) : 81 - 100
  • [2] Itraconazole Inhibits Angiogenesis and Tumor Growth in Non-Small Cell Lung Cancer
    Aftab, Blake T.
    Dobromilskaya, Irina
    Liu, Jun O.
    Rudin, Charles M.
    CANCER RESEARCH, 2011, 71 (21) : 6764 - 6772
  • [3] Tumor angiogenesis as a prognostic marker in operable non-small cell lung cancer
    Matsuyama, K
    Chiba, Y
    Sasaki, M
    Tanaka, H
    Muraoka, R
    Tanigawa, N
    ANNALS OF THORACIC SURGERY, 1998, 65 (05): : 1405 - 1409
  • [4] Endoglin targeting inhibits tumor angiogenesis in non-small cell lung cancer
    Chen, Chiao-Yun
    Sheu, Ming-Jyh
    FASEB JOURNAL, 2018, 32 (01):
  • [5] Tumor angiogenesis and recurrence in stage I non-small cell lung cancer
    Ohta, Y
    Tomita, Y
    Oda, M
    Watanabe, S
    Murakami, S
    Watanabe, Y
    ANNALS OF THORACIC SURGERY, 1999, 68 (03): : 1034 - 1038
  • [6] MicroRNA Signatures in Tumor Tissue Related to Angiogenesis in Non-Small Cell Lung Cancer
    Donnem, Tom
    Fenton, Christopher G.
    Lonvik, Kenneth
    Berg, Thomas
    Eklo, Katrine
    Andersen, Sigve
    Stenvold, Helge
    Al-Shibli, Khalid
    Al-Saad, Samer
    Bremnes, Roy M.
    Busund, Lill-Tove
    PLOS ONE, 2012, 7 (01):
  • [7] Angiogenesis inhibitors in the treatment of small cell and non-small cell lung cancer
    Blackhall, FH
    Shepherd, FA
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2004, 18 (05) : 1121 - +
  • [8] Inhibition of angiogenesis in the treatment of non-small cell lung cancer
    Keedy, Vicki L.
    Sandler, Alan B.
    CANCER SCIENCE, 2007, 98 (12) : 1825 - 1830
  • [9] Emerging angiogenesis inhibitors for non-small cell lung cancer
    Malapelle, Umberto
    Rossi, Antonio
    EXPERT OPINION ON EMERGING DRUGS, 2019, 24 (02) : 71 - 81
  • [10] Angiogenesis and antiangiogenic agents in non-small cell lung cancer
    Galligioni, E
    Ferro, A
    LUNG CANCER, 2001, 34 : S3 - S7